[Interventional therapy of bypass stenoses]

Stephan Baldus1, Christian W Hamm

  • 1Abteilung für Kardiologie, Universitätsklinikum Hamburg-Eppendorf, Hamburg, Germany.

Herz
|October 16, 2002
PubMed

Insights

Percutaneous balloon angioplasty in vein grafts is risky, leading to embolization and heart attacks. New stent designs and embolic protection devices aim to improve safety and effectiveness for these challenging bypass lesions.

Area of Science:

  • Interventional Cardiology
  • Vascular Surgery

Background:

  • Percutaneous balloon angioplasty (PTCA) of aorto-coronary saphenous vein grafts is a high-risk procedure.
  • Associated complications include distal embolization, myocardial infarction, and increased mortality.
  • High restenosis rates persist despite coronary stent implantation.

Purpose of the Study:

  • To review recent advancements in PTCA and stenting for vein grafts.
  • To discuss the influence of novel stent designs, antiplatelet therapies, and embolic protection.
  • To outline future strategies for enhancing percutaneous interventions in bypass lesions.

Main Methods:

  • Literature review of recent studies on vein graft interventions.
  • Analysis of data on stent designs, antiplatelet regimens, and embolic protection devices.
  • Discussion of clinical outcomes and future research directions.

Main Results:

  • New stent designs and embolic protection devices show promise in reducing complications.
  • Optimized antiplatelet strategies may improve procedural safety.
  • Further research is needed to fully elucidate the benefits of these advancements.

Conclusions:

  • Interventions in saphenous vein grafts remain challenging but are improving.
  • Technological and therapeutic innovations are enhancing safety and efficacy.
  • Future directions focus on refining current strategies and exploring novel approaches.
Abstract

Related Concept Videos

Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...